| Proximal tubule bicarbonate reclamation |
1.78 |
2.15e-1 |
21/23 (91.3%) |
CA2;SLC4A4;PCK2;...
|
| Neomycin, kanamycin and gentamicin biosynthesis |
1.68 |
2.04e-1 |
5/5 (100%) |
HK2;HK3;HK1
|
| Melanogenesis |
1.67 |
1.72e-1 |
74/101 (73.27%) |
PLCB1;LEF1;EDNRB;...
|
| Fatty acid elongation |
1.63 |
2.17e-1 |
19/27 (70.37%) |
HACD1;HACD3;PPT2;...
|
| Biosynthesis of unsaturated fatty acids |
1.61 |
2.10e-1 |
21/27 (77.78%) |
HACD1;HACD3;SCD5;...
|
| Gastric acid secretion |
1.61 |
1.86e-1 |
63/76 (82.89%) |
CA2;PLCB1;KCNJ16;...
|
| Cell cycle |
1.59 |
2.20e-1 |
110/124 (88.71%) |
SMC1A;CCNB2;ABL1;...
|
| Collecting duct acid secretion |
1.57 |
2.33e-1 |
22/27 (81.48%) |
CA2;ATP6V1D;SLC4A1
|
| Oocyte meiosis |
1.56 |
2.20e-1 |
90/129 (69.77%) |
SMC1A;CCNB2;PPP2R1B;...
|
| African trypanosomiasis |
1.56 |
2.18e-1 |
32/37 (86.49%) |
PLCB1;APOA1;PRKCA;...
|
| T cell receptor signaling pathway |
1.54 |
2.43e-1 |
93/104 (89.42%) |
NCK1;NFATC3;CDC42;...
|
| Glycolysis / Gluconeogenesis |
1.53 |
2.24e-1 |
56/67 (83.58%) |
ENO2;FBP1;PCK2;...
|
| Adherens junction |
1.53 |
2.20e-1 |
63/71 (88.73%) |
CDC42;TJP1;LEF1;...
|
| Cholesterol metabolism |
1.53 |
2.06e-1 |
44/50 (88%) |
APOA2;APOA1;APOB;...
|
| Focal adhesion |
1.50 |
2.40e-1 |
180/201 (89.55%) |
CDC42;FN1;COL4A5;...
|
| ABC transporters |
1.49 |
2.50e-1 |
37/45 (82.22%) |
ABCC4;ABCG2;ABCA3;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
1.48 |
2.47e-1 |
49/53 (92.45%) |
PLCB1;PRKCA;FXYD2;...
|
| Pancreatic secretion |
1.46 |
2.79e-1 |
87/102 (85.29%) |
CA2;PLCB1;SLC4A4;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
1.46 |
2.77e-1 |
70/77 (90.91%) |
GJA1;LEF1;DMD;...
|
| Proteasome |
1.46 |
2.71e-1 |
44/46 (95.65%) |
PSMD6;PSMB5;PSMA1;...
|
| Hypertrophic cardiomyopathy |
1.46 |
2.59e-1 |
81/90 (90%) |
TTN;DMD;TNNC1;...
|
| Adrenergic signaling in cardiomyocytes |
1.45 |
2.50e-1 |
130/150 (86.67%) |
PLCB1;TNNC1;PPP2R1B;...
|
| Thyroid hormone synthesis |
1.45 |
2.45e-1 |
66/75 (88%) |
PLCB1;ALB;PRKCA;...
|
| Dilated cardiomyopathy |
1.45 |
2.44e-1 |
86/96 (89.58%) |
TTN;DMD;TNNC1;...
|
| Pentose phosphate pathway |
1.44 |
2.37e-1 |
25/30 (83.33%) |
FBP1;PGD;G6PD;...
|
| Wnt signaling pathway |
1.43 |
2.56e-1 |
124/166 (74.7%) |
PLCB1;NFATC3;SFRP1;...
|
| Protein digestion and absorption |
1.43 |
2.49e-1 |
78/103 (75.73%) |
COL5A2;COL4A5;COL6A3;...
|
| Starch and sucrose metabolism |
1.42 |
2.70e-1 |
25/36 (69.44%) |
MGAM;HK2;GBE1;...
|
| Complement and coagulation cascades |
1.41 |
2.77e-1 |
76/85 (89.41%) |
SERPINA1;FGG;C5;...
|
| Amoebiasis |
1.40 |
2.88e-1 |
99/102 (97.06%) |
PLCB1;FN1;COL4A5;...
|
| Cocaine addiction |
-1.08 |
9.02e-1 |
42/49 (85.71%) |
DDC;JUN;ATF2;...
|
| Glycerophospholipid metabolism |
-1.11 |
8.89e-1 |
71/98 (72.45%) |
PLPP2;PEMT;ETNPPL;...
|
| Antigen processing and presentation |
-1.14 |
8.49e-1 |
60/78 (76.92%) |
HLA-DPA1;HLA-E;HLA-F;...
|
| Transcriptional misregulation in cancer |
-1.14 |
8.71e-1 |
158/192 (82.29%) |
KLF3;CDKN2C;NR4A3;...
|
| Glioma |
-1.14 |
8.98e-1 |
67/75 (89.33%) |
PDGFRB;PTEN;IGF1;...
|
| Breast cancer |
-1.15 |
9.01e-1 |
119/147 (80.95%) |
NRAS;FGF20;PIK3CA;...
|
| Olfactory transduction |
-1.16 |
8.52e-1 |
69/440 (15.68%) |
OR2B2;OR2H2;OR12D3;...
|
| p53 signaling pathway |
-1.17 |
8.39e-1 |
63/73 (86.3%) |
CCNG1;CDK1;SFN;...
|
| Type I diabetes mellitus |
-1.17 |
8.58e-1 |
38/43 (88.37%) |
IL1B;HLA-DPA1;HLA-E;...
|
| Acute myeloid leukemia |
-1.19 |
8.16e-1 |
66/67 (98.51%) |
STAT5B;RUNX1T1;MYC;...
|
| Fatty acid biosynthesis |
-1.19 |
8.44e-1 |
16/18 (88.89%) |
ACSBG2;ACSL6;ACACB;...
|
| Mannose type O-glycan biosynthesis |
-1.19 |
8.73e-1 |
14/23 (60.87%) |
B4GALT3;B4GALT1;FUT9;...
|
| Nucleotide excision repair |
-1.19 |
8.81e-1 |
40/47 (85.11%) |
ERCC1;POLD4;GTF2H3;...
|
| Lysosome |
-1.23 |
8.83e-1 |
115/128 (89.84%) |
NAGLU;AP1B1;SMPD1;...
|
| Regulation of lipolysis in adipocytes |
-1.26 |
7.55e-1 |
52/55 (94.55%) |
LIPE;CGA;GNAS;...
|
| Arachidonic acid metabolism |
-1.27 |
7.70e-1 |
48/61 (78.69%) |
PLA2G5;PTGDS;CBR3;...
|
| Melanoma |
-1.27 |
7.98e-1 |
68/72 (94.44%) |
PDGFRB;PTEN;IGF1;...
|
| Bladder cancer |
-1.29 |
7.50e-1 |
40/41 (97.56%) |
MYC;VEGFA;CDK4;...
|
| Prostate cancer |
-1.29 |
8.04e-1 |
93/97 (95.88%) |
PDGFRB;NFKB1;PTEN;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.31 |
7.71e-1 |
49/77 (63.64%) |
CBR3;SULT2A1;CYP2F1;...
|
| Systemic lupus erythematosus |
-1.33 |
7.31e-1 |
45/135 (33.33%) |
C1R;HLA-DQB1;C1S;...
|
| Ribosome |
-1.33 |
7.84e-1 |
113/158 (71.52%) |
MRPS14;RPL36A;RPL24;...
|
| Caffeine metabolism |
-1.34 |
8.21e-1 |
5/6 (83.33%) |
XDH;NAT2;NAT1;...
|
| Retinol metabolism |
-1.36 |
8.25e-1 |
41/68 (60.29%) |
CYP26B1;ADH1B;UGT2B17;...
|
| Phosphonate and phosphinate metabolism |
-1.41 |
7.29e-1 |
5/6 (83.33%) |
CEPT1;CHPT1
|
| Other glycan degradation |
-1.43 |
7.62e-1 |
13/18 (72.22%) |
MANBA;HEXB;FUCA1;...
|
| alpha-Linolenic acid metabolism |
-1.49 |
6.17e-1 |
17/25 (68%) |
PLA2G4C;PLA2G1B;PLA2G5;...
|
| Linoleic acid metabolism |
-1.50 |
7.69e-1 |
21/29 (72.41%) |
PLA2G4C;ALOX15;PLA2G1B;...
|
| Aminoacyl-tRNA biosynthesis |
-1.58 |
6.35e-1 |
15/66 (22.73%) |
GATB;NARS2;HARS2;...
|
| Chronic myeloid leukemia |
-1.64 |
7.07e-1 |
72/76 (94.74%) |
STAT5B;MYC;BAD;...
|